Literature DB >> 15899873

Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.

Alicia S Chung1, Ying-Jie Guan, Zheng-Long Yuan, Jorge E Albina, Y Eugene Chin.   

Abstract

Ankyrin repeat and SOCS box (ASB) family members have a C-terminal SOCS box and an N-terminal ankyrin-related sequence of variable repeats belonging to the SOCS superfamily. While SH2-domain-bearing SOCS proteins are mainly involved in the negative feedback regulation of the protein tyrosine kinase-STAT pathway in response to a variety of cytokines, the roles of ASB family members remain largely unknown. To investigate ASB functions, we screened for ASB3-interacting factors by using antibody array technology and identified tumor necrosis factor receptor II (TNF-R2) as an ASB3 binding target. ASB3 expression and activities are required for (i) TNF-R2 ubiquitination both in vivo and in vitro, (ii) TNF-R2 proteolysis via the proteasome pathway, and (iii) the inhibition of TNF-R2-mediated Jun N-terminal protein kinase (JNK) activation. While the ankyrin repeats of ASB3 interact with the C-terminal 37 amino acids of TNF-R2, the SOCS box of ASB3 is responsible for recruiting the E3 ubiquitin ligase adaptors Elongins-B/C, leading to TNF-R2 ubiquitination on multiple lysine residues within its C-terminal region. Downregulation of ASB3 expression by a small interfering RNA inhibited TNF-R2 degradation and potentiated TNF-R2-mediated cytotoxicity. The data presented here implicate ASB3 as a negative regulator of TNF-R2-mediated cellular responses to TNF-alpha by direct targeting of TNF-R2 for ubiquitination and proteasome-mediated degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899873      PMCID: PMC1140645          DOI: 10.1128/MCB.25.11.4716-4726.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells.

Authors:  Stanimir S Ivanov; Alicia S Chung; Zheng-long Yuan; Ying-jie Guan; Katherine V Sachs; Jonathan S Reichner; Y Eugene Chin
Journal:  Mol Cell Proteomics       Date:  2004-05-03       Impact factor: 5.911

Review 2.  Function and regulation of tumor necrosis factor receptor type 2.

Authors:  I Carpentier; B Coornaert; R Beyaert
Journal:  Curr Med Chem       Date:  2004-08       Impact factor: 4.530

3.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.

Authors:  M Rothe; V Sarma; V M Dixit; D V Goeddel
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

4.  Structural basis for self-association and receptor recognition of human TRAF2.

Authors:  Y C Park; V Burkitt; A R Villa; L Tong; H Wu
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

5.  The p70 tumor necrosis factor receptor mediates cytotoxicity.

Authors:  R A Heller; K Song; N Fan; D J Chang
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

6.  Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.

Authors:  A Kibel; O Iliopoulos; J A DeCaprio; W G Kaelin
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

7.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Authors:  Yibin Deng; Xiaoyang Ren; Lin Yang; Yahong Lin; Xiangwei Wu
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

8.  Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities.

Authors:  A E Medvedev; A Sundan; T Espevik
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

9.  Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts.

Authors:  A Sarin; M Conan-Cibotti; P A Henkart
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

10.  Induction of apoptosis in mature T cells by tumour necrosis factor.

Authors:  L Zheng; G Fisher; R E Miller; J Peschon; D H Lynch; M J Lenardo
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

View more
  32 in total

1.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain.

Authors:  Ziba Razinia; Massimiliano Baldassarre; Mohamed Bouaouina; Isabelle Lamsoul; Pierre G Lutz; David A Calderwood
Journal:  J Cell Sci       Date:  2011-07-12       Impact factor: 5.285

3.  Phospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration.

Authors:  Ying-Jie Guan; Zhe Zhang; Chen Yu; Li Ma; Weiling Hu; Li Xu; Jin-Song Gao; Chun-Shiang Chung; Lijuan Wang; Zhong-Fa Yang; Loren D Fast; Alicia S Chung; Minsoo Kim; Alfred Ayala; Shougang Zhuang; Shusen Zheng; Y Eugene Chin
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

4.  Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase.

Authors:  Christina Aaen Andresen; Stine Smedegaard; Kathrine Beck Sylvestersen; Charlotte Svensson; Diego Iglesias-Gato; Giuseppe Cazzamali; Tine Kragh Nielsen; Michael Lund Nielsen; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

5.  Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.

Authors:  Lei Nie; Ying Zhao; Wei Wu; Yuan-Zheng Yang; Hong-Cheng Wang; Xiao-Hong Sun
Journal:  Cell Res       Date:  2010-11-30       Impact factor: 25.617

6.  Crystal structure of Human ASB9-2 and substrate-recognition of CKB.

Authors:  Xiangwei Fei; Xing Gu; Shilong Fan; Zhenxing Yang; Fan Li; Cheng Zhang; Weimin Gong; Yumin Mao; Chaoneng Ji
Journal:  Protein J       Date:  2012-04       Impact factor: 2.371

7.  ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.

Authors:  Sanghoon Kwon; Dongbum Kim; Jae Won Rhee; Jeong-A Park; Dae-Won Kim; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Biol       Date:  2010-03-19       Impact factor: 7.431

Review 8.  Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology.

Authors:  Jin-Ming Tee; Maikel P Peppelenbosch
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

9.  A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature.

Authors:  Yueyi Feng; Yiqing Jiang; Qingting Feng; Lingkai Xu; Yun Jiang; Fang Meng; Xiaochen Shu
Journal:  Cancer Biol Ther       Date:  2020-11-05       Impact factor: 4.742

Review 10.  Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.

Authors:  Kate E Keller; Mary K Wirtz
Journal:  Exp Eye Res       Date:  2016-06-11       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.